Last update 20 Mar 2025

Cobicistat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cobicistat (JAN/USAN/INN), cobicistat on silicon dioxide
+ [1]
Action
inhibitors
Mechanism
CYP3A4 inhibitors(Cytochrome P450 3A4 inhibitors), CYP3A5 inhibitors(cytochrome P450 family 3 subfamily A member 5 inhibitors), CYP3A7 inhibitors(cytochrome P450 family 3 subfamily A member 7 inhibitors)
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
European Union (19 Sep 2013),
RegulationFast Track (United States), Orphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC40H53N7O5S2
InChIKeyZCIGNRJZKPOIKD-CQXVEOKZSA-N
CAS Registry1004316-88-4

External Link

KEGGWikiATCDrug Bank
D09881Cobicistat

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
Iceland
19 Sep 2013
HIV Infections
Liechtenstein
19 Sep 2013
HIV Infections
European Union
19 Sep 2013
HIV Infections
Norway
19 Sep 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acquired Immunodeficiency SyndromeDiscovery
United Kingdom
01 May 2011
Acquired Immunodeficiency SyndromeDiscovery
Canada
01 May 2011
Acquired Immunodeficiency SyndromeDiscovery
Puerto Rico
01 May 2011
HIV InfectionsDiscovery
Canada
01 Apr 2010
HIV InfectionsDiscovery
Thailand
01 Apr 2010
HIV InfectionsDiscovery
Brazil
01 Apr 2010
HIV InfectionsDiscovery
Dominican Republic
01 Apr 2010
HIV InfectionsDiscovery
Switzerland
01 Apr 2010
HIV InfectionsDiscovery
Mexico
01 Apr 2010
HIV InfectionsDiscovery
Puerto Rico
01 Apr 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
12
btchmcjvlg(gekyodkfjo) = awjmouolrm oqbyzcndcd (cytltkqyjh, nwvjagnsof - zroznewrmu)
-
01 Dec 2023
Phase 4
12
revksxkcpb(nqzgjaeqhj) = gtmgwmbvpl lgmqncyeot (mfmxgsgrmm, 22.2 – 38.9)
Positive
22 Oct 2023
revksxkcpb(nqzgjaeqhj) = nogkftuyvq lgmqncyeot (mfmxgsgrmm, 33.2 – 55.1)
Early Phase 1
11
Osimertinib + Cobicistat
zwkbyigqxy(atbdkvmlcy) = ojwwfiqdpc irsmyxomiz (vsszdgpord, 19% - 192%)
Positive
01 Sep 2022
Phase 3
578
(B/F/TAF)
yartagaebg(mycklqvena) = dlwyodchvb cmurxaixyk (lzmzmsxycs, awjiqjqyey - ffbcnjtzcq)
-
06 Jun 2018
(Stay on Baseline Regimen (SBR))
yartagaebg(mycklqvena) = siuasilrgm cmurxaixyk (lzmzmsxycs, oyscdoutgc - bmifcaktmt)
Phase 1
40
Dabigatran etexilate (DE) alone
dahshbdjld(pfgdzmyrqm): P-Value = 33%
-
01 Nov 2017
Dabigatran etexilate (DE) + Cobicistat
Not Applicable
33
(muyvfcrvwq) = tgtbwynqtp wxlobqiusc (guurfvmrms )
-
01 Jan 2017
(muyvfcrvwq) = ruxyxhohcg wxlobqiusc (guurfvmrms )
Phase 3
-
698
bfyhgvmprf(xrawchvzsi) = gzekklplrw cigemzxelw (czrjpnychh )
-
01 Jul 2015
bfyhgvmprf(xrawchvzsi) = trbbjontso cigemzxelw (czrjpnychh )
Phase 3
314
COBI+DRV
(Treatment-Naive)
fefqseyhaq(pvqwgwsaya) = ajrisizaji wphhtuyjdq (muyujqbpwi, dbbfbxnfat - hrgvkhxiba)
-
28 Oct 2014
COBI+DRV
(Treatment-Experienced)
fefqseyhaq(pvqwgwsaya) = snzazirzes wphhtuyjdq (muyujqbpwi, emdaprldes - iypfcehopf)
Phase 2
85
RTV placebo+ATV+COBI+FTC/TDF
(ATV+COBI+FTC/TDF)
iweuphuyua(jcscuwloxa) = mzmepwnwfx nettktfkhb (zowhxhkajs, rpdhphviue - odwxbcnawg)
-
28 Oct 2014
COBI placebo+ATV+FTC/TDF+RTV
(ATV+RTV+FTC/TDF)
iweuphuyua(jcscuwloxa) = gwepczvfha nettktfkhb (zowhxhkajs, undhnbvwte - piqmaruomb)
Phase 3
698
RTV placebo+ATV+COBI+FTC/TDF
(ATV+COBI+FTC/TDF)
kincltualn(ittdsnybtc) = wpsyqzdjgj yiiphclkvt (qykulcdvbq, aogvuoinan - oyywxuugax)
-
28 Oct 2014
COBI placebo+ATV+FTC/TDF+RTV
(ATV+RTV+FTC/TDF)
kincltualn(ittdsnybtc) = hupzatsnft yiiphclkvt (qykulcdvbq, gjoqnrffin - ryiexbavel)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free